World registry on factor VIII inhibitor patients: why?
作者信息
Aledort L M
机构信息
Mount Sinai School of Medicine, New York, NY 10029.
出版信息
Semin Hematol. 1993 Apr;30(2 Suppl 1):7-9.
PMID:8480198
Abstract
摘要
相似文献
1
World registry on factor VIII inhibitor patients: why?
Semin Hematol. 1993 Apr;30(2 Suppl 1):7-9.
2
Factor VIII inhibitors.凝血因子VIII抑制剂
Thromb Haemost. 1997 Jul;78(1):641-6.
3
Previously untreated patients and recombinant factor VIII concentrate studies.既往未经治疗的患者及重组凝血因子VIII浓缩剂研究。
Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S29-32.
4
5
Recombinant factor VIII in hemophilia.
N Engl J Med. 1991 May 23;324(21):1515-6.
6
Factor VIII inhibitor and severity of hemophilia.
Thromb Haemost. 1996 Aug;76(2):280-1.
7
[Recombinant factor VIII].[重组凝血因子 VIII]
Sangre (Barc). 1993 Apr;38(2):139-42.
8
Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A.第二代重组凝血因子VIII与抑制物风险：解读RODIN研究结果及其对甲型血友病患者的影响
Haemophilia. 2014 Mar;20(2):e171-4. doi: 10.1111/hae.12342. Epub 2013 Dec 26.
9
10
The challenges of inhibitor patient care.抑制剂患者护理的挑战。
Semin Hematol. 1993 Apr;30(2 Suppl 1):1-2.
Zotero 插件